| Schedule of Net Income (Loss) Per Share |
The net
income (loss) per share presented in the unaudited condensed consolidated statements of income
(loss) is based on the following:
| | |
FOR THE
SIX MONTHS ENDED
JUNE
30, 2025 | | |
FOR THE
PERIOD FROM
MARCH 8,
2024
(INCEPTION) TO
JUNE 30, 2024 | |
| | |
Redeemable
Ordinary
Shares | | |
Non-Redeemable
Ordinary
Shares | | |
Redeemable
Ordinary
Shares | | |
Non-Redeemable
Ordinary
Shares | |
| Basic and diluted net income (loss) per share: | |
| | |
| | |
| | |
| |
| Numerators: | |
| | |
| | |
| | |
| |
| Interest income earned in investments held in Trust Account | |
$ | 1,205,604 | | |
$ | - | | |
$ | - | | |
$ | - | |
| Total expenses | |
| (270,469 | ) | |
| (82,287 | ) | |
| - | | |
| (38,860 | ) |
| Total allocation to redeemable and non-redeemable ordinary shares | |
$ | 935,135 | | |
$ | (82,287 | ) | |
$ | - | | |
$ | (38,860 | ) |
| Denominators: | |
| | | |
| | | |
| | | |
| | |
| Weighted-average shares outstanding | |
| 5,750,000 | | |
| 1,749,375 | | |
| - | | |
| 1,019,737 | |
| Basic and diluted net income (loss) per share | |
$ | 0.16 | | |
$ | (0.05 | ) | |
$ | | | |
$ | (0.04 | ) |
| | |
FOR THE
THREE MONTHS ENDED
JUNE
30, 2025 | | |
FOR THE
THREE MONTHS ENDED
JUNE 30, 2024 | |
| | |
Redeemable
Ordinary
Shares | | |
Non-Redeemable
Ordinary
Shares | | |
Redeemable
Ordinary
Shares | | |
Non-Redeemable
Ordinary
Shares | |
| Basic and diluted net income (loss) per share: | |
| | |
| | |
| | |
| |
| Numerators: | |
| | |
| | |
| | |
| |
| Interest income earned in investments held in Trust Account | |
$ | 608,447 | | |
$ | - | | |
$ | - | | |
$ | - | |
| Total expenses | |
| (160,604 | ) | |
| (48,862 | ) | |
| - | | |
| (10,000 | ) |
| Total allocation to redeemable and non-redeemable ordinary shares | |
$ | 447,843 | | |
$ | (48,862 | ) | |
$ | - | | |
$ | (10,000 | ) |
| Denominators: | |
| | | |
| | | |
| | | |
| | |
| Weighted-average shares outstanding | |
| 5,750,000 | | |
| 1,749,375 | | |
| - | | |
| 1,250,000 | |
| Basic and diluted net income (loss) per share | |
$ | 0.08 | | |
$ | (0.03 | ) | |
$ | | | |
$ | (0.01 | ) |
|
| Schedule of Assets and Liabilities that were Measured at Fair Value on a Recurring Basis |
The following table presents information about
the Company’s assets and liabilities that were measured at fair value on a recurring basis as of June 30, 2025 and December 31,
2024, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.
| | |
June 30, | | |
Quoted
Prices In
Active
Markets | | |
Significant
Other
Observable
Inputs | | |
Significant
Other
Unobservable
Inputs | |
| Description | |
2025 | | |
(Level 1) | | |
(Level 2) | | |
(Level 3) | |
| Assets: | |
| | |
| | |
| | |
| |
| Investment held in Trust Account | |
$ | 59,536,150 | | |
$ | 59,536,150 | | |
$ | - | | |
$ | - | |
| | |
December 31, | | |
Quoted
Prices In
Active
Markets | | |
Significant
Other
Observable
Inputs | | |
Significant
Other
Unobservable
Inputs | |
| Description | |
2024 | | |
(Level 1) | | |
(Level 2) | | |
(Level 3) | |
| Assets: | |
| | |
| | |
| | |
| |
| Investment held in Trust Account | |
$ | 58,330,546 | | |
$ | 58,330,546 | | |
$ | - | | |
$ | - | |
|